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Abstract
Background: The burden of non-communicable diseases (NCDs) is increasing in sub-Saharan Africa, but data
available for intervention planning are inadequate. We determined the prevalence of selected NCDs and HIV
infection, and NCD risk factors in northwestern Tanzania and southern Uganda.
Methods: A population-based cross-sectional survey was conducted, enrolling households using multistage sampling
with five strata per country (one municipality, two towns, two rural areas). Consenting adults (≥18 years) were
interviewed using the WHO STEPS survey instrument, examined, and tested for HIV and diabetes mellitus (DM).
Adjusting for survey design, we estimated population prevalences of hypertension, DM, obstructive pulmonary
disease, cardiac failure, epilepsy and HIV, and investigated factors associated with hypertension using logistic
regression.
Results: Across strata, hypertension prevalence ranged from 16 % (95 % confidence interval (CI): 12 % to 22 %) to
17 % (CI: 14 % to 22 %) in Tanzania, and from 19 % (CI: 14 % to 26 %) to 26 % (CI: 23 % to 30 %) in Uganda. It
was high in both urban and rural areas, affecting many young participants. The prevalence of DM (1 % to 4 %)
and other NCDs was generally low. HIV prevalence ranged from 6 % to 10 % in Tanzania, and 6 % to 12 % in
Uganda. Current smoking was reported by 12 % to 23 % of men in different strata, and 1 % to 3 % of women.
Problem drinking (defined by Alcohol Use Disorder Identification Test criteria) affected 6 % to 15 % men and 1 %
to 6 % women. Up to 46 % of participants were overweight, affecting women more than men and urban more
than rural areas. Most patients with hypertension and other NCDs were unaware of their condition, and
hypertension in treated patients was mostly uncontrolled. Hypertension was associated with older age, male sex,
being divorced/widowed, lower education, higher BMI and, inversely, with smoking.
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Conclusions: The high prevalence of NCD risk factors and unrecognized and untreated hypertension represent
major problems. The low prevalence of DM and other preventable NCDs provides an opportunity for prevention.
HIV prevalence was in line with national data. In Tanzania, Uganda and probably elsewhere in Africa, major efforts
are needed to strengthen health services for the PREVENTION, early detection and treatment of chronic diseases.
Keywords: Non-communicable diseases, hypertension, diabetes mellitus, heart failure, obstructive pulmonary
disease, HIV infection, NCD risk factors, WHO STEPS survey, Africa
Background
Historically, acute illnesses have been the most important
health problems in sub-Saharan Africa (SSA). However,
there is growing evidence that the burden of chronic dis-
eases (CDs), in particular that of non-communicable dis-
eases (NCDs), is increasing rapidly in this region [1]. It
has been anticipated that NCDs may account for 46 % of
deaths in SSA by 2030, compared to 28 % in 2008 [1].
Hypertension, diabetes mellitus (DM), ischemic heart dis-
ease and heart failure are of particular concern; however,
precise epidemiological data are rare [2–5]. Data on the
prevalence of chronic respiratory diseases, such as asthma
and chronic obstructive pulmonary diseases (COPD), are
even more limited. These diseases are likely to become
more prevalent as risk factors become more common [6].
In addition, owing to longer survival following increased
access to care and antiretroviral therapy, HIV has also be-
come a CD [7].
Urbanization and associated lifestyle changes, as well as
improvements in life expectancy, may explain the increase
in NCDs in SSA. More people are engaged in sedentary
work and physical activity during leisure time is uncom-
mon [8, 9]. Moreover, populations are increasingly ex-
posed to diets that are high in calories, salt and fat with
low fiber content [10]. Fetal and childhood malnutrition,
prevalent in Africa, may also contribute to the increasing
prevalence of cardiovascular diseases and DM [11, 12].
Various factors including increases in air pollution, the use
of biomass fuel and tobacco are likely to result in chronic
lung disease [6, 13].
However, data on the burden of NCDs in SSA are lim-
ited, and only a few representative community-based stud-
ies have been conducted [14]. Data from well-designed
epidemiological studies are needed to accurately estimate
the prevalence of NCDs in SSA and to facilitate the plan-
ning of effective interventions. For this study, we hypothe-
sized that the burden of NCDs in Tanzania and Uganda is
high and is associated with modifiable risk factors. We re-
port the prevalence of risk factors for NCDs, the preva-
lence of selected CDs, and of factors associated with
hypertension in northwestern Tanzania and southern
Uganda. HIV infection was included for comparison as
our work forms part of an ongoing research program that
aims to investigate the burden of selected CDs in the
general population and within health facilities, and to con-
tribute to the design of intervention programs for the im-
provement of CD disease services in these countries.
Methods
Study design, setting and sampling
We conducted a cross-sectional population survey among
adults (≥18-years old) between May 2012 and April 2013.
We used stratified, multistage sampling, with five strata in
each country: a municipal area (Mwanza city in Tanzania;
Entebbe town in Uganda), two district towns (Geita and
Kahama in Tanzania; Wakiso and Mpigi in Uganda), and
the rural districts corresponding to each district town. We
took an independent two-stage self-weighting sample
from each stratum, firstly sampling the lowest administra-
tive local authority areas with probability proportional to
the number of households, and secondly randomly sam-
pling households within these areas (see Additional file 1
for further details). Households were eligible if they were
located within 5 km of a health facility which in both
countries is the case for all urban and the great majority
of rural homes.
Selected households were visited, verbal consent from
household heads obtained, a list of adult household
members prepared, and all resident adults invited to par-
ticipate. Consenting participants were recruited. No re-
placements were made for households that refused
participation or for participants who could not be con-
tacted after three repeat visits.
Sample size
We aimed to measure the prevalence of important con-
ditions with a precision that would provide sufficiently
reliable information for intervention planning. For ex-
ample, we aimed at estimating the prevalence of a condi-
tion that occurs in 5 % of the study population with a
precision of +/− 3.3 %. Based on pilot work within the
project area, we expected an average number of eligible
persons per household of 1.76. Using this number, and
assuming a design effect of 3, an overall sample size was
required of 792 per country. This number of individuals
could be expected to be found in 450 households. To
allow for possible errors in the assumed number of par-
ticipants per household and for a lack of response, we
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increased the sample size by 20 % overall and thus
aimed for 540 households with a total of 950 partici-
pants per country.
Data collection
Participants were interviewed in their homes or at a nearby
communal location using a structured questionnaire
adapted from the World Health Organization (WHO)
STEPwise approach to CD risk factor surveillance (STEPS)
instrument [15]. We collected information on socio-
demographic characteristics, risk factors for NCDs, symp-
toms related to NCDs, and disease and treatment history.
Information about alcohol use was collected using the Al-
cohol Use Disorders Identification Test (AUDIT) [16].
Physical examinations were conducted to determine
weight, height, waist circumference, blood pressure (BP)
and lung function. Weight was measured using a digital
seca® 813 scale, height using a seca® 213 stadiometer and
waist circumference using a 203 cm seca® measuring
tape (all seca GmbH & Co. KG., Hamburg, Germany),
with the mean of two waist circumference measure-
ments used for analysis. BP was measured with partici-
pants seated after resting for at least 15 minutes, using
the Omron digital automatic blood pressure monitor
model M6 (Omron Health Care Manufacturing Vietnam
Co., Ltd, Binh Duong Province, Vietnam) with an inflat-
able cuff (small, medium or large size depending on the
upper arm circumference). We measured BP once on
each arm, and then obtained a third measurement from
the arm with the highest value. This third measurement
was used for analysis. Lung function tests were per-
formed using Vitalograph® micro model 6300 (Vitalo-
graph, Enis, Ireland) and forced expiratory volume in the
first second (FEV1) and forced vital capacity (FVC) were
recorded. For each participant, we aimed for five satis-
factory spirometer tests. The mean of the two highest
spirometer results was used for analysis [17].
Blood samples were collected for HIV rapid testing
and random blood glucose (RBG). Participants with a
RBG result of ≥7 mmol/L were re-visited for a fasting
blood glucose (FBG) test within five days of RBG testing.
Laboratory tests
Whole venous blood was tested for RBG using a
portable-battery driven Accu-Check® Aviva (Roche
Diagnostics GmbH, Mannheim, Germany) and FBG
using HemoCue® Glucose 201 RT (HemoCue AB,
Ängelholm, Sweden). HIV testing was performed using
approved testing algorithms in each country. In both
countries, Determine™ HIV1/2 (Alere Medical Co. Ltd.,
Mitsudo-shi, Chiba, Japan) was used as a first-line test and
negative results were recorded as such. Positive samples
were confirmed by Uni-Gold™ HIV (Trinity Biotech, Plc,
Bray, Co.Wicklow, Ireland) in Tanzania and HIV 1/2
STAT-PAK® (Chembio Diagnostic Systems Inc, Medford,
NY, USA) in Uganda. In case of discrepant results, HIV 1/
2 STAT-PAK® in Tanzania and Uni-Gold™ HIV in Uganda
were used as tiebreakers.
Diagnosis of NCDs
Hypertension was defined according to the seventh report
of the internationally recognized Joint National Com-
mittee as systolic BP ≥140 mmHg and/or diastolic
BP ≥90 mmHg, or currently taking medication for hyper-
tension [18]. We further classified hypertension as stage II
(systolic BP ≥160 mmHg and/or diastolic BP ≥100 mmHg)
or stage I (those with hypertension but not meeting the
definition of stage II), among those not on treatment.
DM was defined as RBG >11.1 mmol/L or FBG ≥7 mmol/
L or being on diabetes medication. Heart failure was diag-
nosed, according to the Framingham criteria [19], if the
following conditions were present: orthopnea or parox-
ysmal nocturnal dyspnea (PND), and at least two of
three additional heart failure symptoms (edema, re-
ported breathlessness on exertion, heart rate >120 beats
per minute); or orthopnea and PND, and at least one of
the three additional symptoms. Obstructive lung dis-
ease was defined as FEV1/FVC ≤0.7 according to the
Global Initiative for Chronic Obstructive Lung Disease
[17]. Epilepsy was diagnosed if participants reported to
be on antiepileptic treatment or reported that they ex-
perienced seizures during the past 12 months.
Anthropometric classification
Body mass index (BMI, kg/m2) was classified as under-
weight (<18.5), normal (18.5 to < 25), overweight (25
to <30) and obese (≥30). Waist circumference >94 cm
and >80 cm was classified as above normal (central
obesity) for males and females, respectively [20].
Statistical analysis
In Uganda, data were entered on Ultra Mobile Personal
Computers in the field, using Microsoft Access. In
Tanzania, data were collected on paper-based forms in the
field, and subsequently double-entered in OpenClinica®
version 3.0.1 (OpenClinica, Waltham, MA, USA). Ana-
lyses were conducted with Stata Version 13. We used the
Stata survey procedures to account for the complex sam-
pling design, and sampling weights to account for differ-
ential probability of selection between strata and, in
Tanzania, between clusters (see Additional file 1).
We tabulated the population socio-demographic charac-
teristics, and prevalences of CDs and potential NCD risk
factors, stratified by country and location (municipalities,
district towns, and rural), and by sex for the prevalences
of potential NCD risk factors and hypertension. In
addition, the weighted estimates of CD prevalence in each
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location were age-standardized using the WHO world
population aged 18+ as reference [21].
We investigated factors associated with hypertension,
combining data from both countries and using logistic
regression to estimate odds ratios (OR) and 95 % confi-
dence intervals (CI). We did not investigate risk factors
for other NCDs because the prevalences were low. We
used the Stata survey procedures to adjust the standard
errors for the survey design. We adjusted for age, sex
and stratum a priori in all models, so comparisons were
essentially within the (approximately self-weighted)
strata and sampling weights were not applied. Potential
determinants of hypertension were examined using a
conceptual framework with three levels [22]. Socio-
demographic factors were added to the stratum, age and
sex-adjusted analysis and retained if associated with
hypertension at P <0.10. Behavioral factors were then
added one by one and retained if they remained associated
at P <0.10. Associations with anthropometric factors were
subsequently determined in a similar way. This strategy
allowed us to assess the effects of variables at each level of
the framework, adjusted for more distal variables. We esti-
mated the population attributable fraction (PAF) of hy-
pertension for overweight and obese BMI, and central
obesity, using the adjusted ORs from the final model.
Lastly, we did a similar analysis to explore factors associ-
ated with untreated stage II hypertension.
Ethical considerations
This study was approved by the ethics committees of
the Tanzanian National Institute for Medical Research,
Uganda Virus Research Institute, Ugandan National
Council for Science and Technology, and London School
of Hygiene and Tropical Medicine. We obtained written
informed consent (witnessed for illiterate participants)
from all participants before administering study proce-
dures. Participants were interviewed in privacy to ensure
confidentiality, and no personal identifiers were included
on the questionnaire. A trained clinician/nurse offered
pre-test and post-test counselling for all CDs investigated
in this study. Minor ailments were treated on the spot.
Participants with a known or newly-diagnosed CD (in-
cluding HIV infection) were referred to a health center or
hospital for further assessment, counselling, and long-
term care and treatment. HIV infected individuals were
assessed for eligibility to antiretroviral therapy (ART) by
existing ART providers or in case of shortage of CD4 tests
by the research teams.
Results
Population characteristics
In Tanzania, we enrolled 175 adults in Mwanza munici-
pality, 344 in district towns and 576 in rural communi-
ties, providing a total of 1,095 participants from 563
households (Fig. 1). In Uganda, we enrolled 206 people
Fig. 1 Households and participants sampled and reasons for non-participation
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Table 1 Characteristics of study population
Tanzania - Total respondents Mwanza municipality (number = 175) District towns (number = 344) Rural (number = 576)
Weighted %
(95 % CI)a
Unweighted Nb Weighted %
(95 % CI)a
Unweighted Nb Weighted %
(95 % CI)a
Unweighted Nb
Sex
Male 44.3 % (35.6–53.4) 77 44.6 % (37.9–51.6) 153 48.2 % (44.1–52.3) 275
Female 55.7 % (46.6–64.4) 98 55.4 % (48.4–62.1) 191 51.8 % (47.7–55.9) 301
Age (years)
18–24 30.2 % (21.4-40.6) 53 31.6 % (28.4-35.1) 110 26.1 % (21.7-31.0) 145
25–34 32.2 % (19.9-47.6) 57 38.4 % (31.2-46.2) 130 26.9 % (22.5-31.9) 156
35–44 15.8 % (9.5 -25.0) 29 15.2 % (11.4-19.9) 52 15.9 % (13.1-19.2) 93
≥45 21.8 % (16.1-29.0) 36 14.8 % (9.8 -21.6) 52 31.1 % (26.8-35.7) 182
Marital status
Married/living as married 55.6 % (45.5–65.3) 98 60.6 % (54.1–66.7) 205 70.5 % (67.1–73.8) 410
Divorced/separated/widowed 16.4 % (11.8–22.3) 27 12.6 % (7.9–19.6) 46 17.3 % (13.1–22.5) 96
Single 28.0 % (20.6–36.8) 50 26.8 % (21.3–33.2) 93 12.2 % (9.3–15.7) 70
Education
None/incomplete primary 21.1 % (14.6–29.6) 34 20.5 % (15.3–27.0) 72 49.2 % (41.7–56.7) 276
Completed primary 48.5 % (43.7–53.4) 85 49.9 % (44.6–55.2) 170 42.9 % (37.4–48.6) 254
Secondary 27.0 % (20.5–34.7) 51 24.7 % (18.4–32.2) 85 7.5 % (5.0–11.3) 44
Above secondary 3.4 % (1.2–9.0 ) 5 4.9 % (2.7–8.6 ) 17 0.4 % (0.1–1.5 ) 2
Monthly income (USD)c
Weighted median (IQR) 38 USD (19–114) 57 USD (25–127) 19 USD (10–38)
Uganda - Total respondents Entebbe municipality (number = 206) District towns (number = 278) Rural (number = 432)
Sex
Male 38.3 % (33.6–43.3) 79 41.0 % (34.4–48.1) 108 42.5 % (37.3–47.9) 188
Female 61.7 % (56.7–66.4) 127 59.0 % (51.9–65.6) 170 57.5 % (52.1–62.7) 244
Age (years)
18–24 30.1 % (23.1-38.1) 62 37.6 % (29.4-46.6) 94 25.8 % (20.3-32.2) 105
25–34 35.4 % (29.4-41.9) 73 32.2 % (25.9-39.1) 87 22.4 % (17.5-28.3) 95
35–44 15.5 % (12.3-19.4) 32 11.5 % (7.0 -18.4) 45 17.6 % (14.4-21.2) 78
≥45 18.9 % (16.5-21.7) 39 18.7 % (15.2-22.8) 52 34.2 % (27.0-42.3) 154
Marital status
Married/living as married 44.7 % (34.7–55.0) 92 52.7 % (44.7–60.6) 157 54.8 % (47.0–62.4) 245
Divorced/separated/widowed 17.0 % (11.7–24.1) 35 16.1 % (10.3–24.5) 45 23.0 % (18.7–27.9) 102
Single 38.3 % (29.6–47.9) 79 31.2 % (25.2–37.9) 76 22.2 % (16.3–29.5) 85
Education
None/incomplete primary 17.5 % (9.7–29.4) 36 22.2 % (18.4–26.4) 67 42.3 % (32.5–52.8) 198
Completed primary 12.6 % (7.4–20.8) 26 11.7 % (6.3–20.6) 34 18.5 % (15.4–22.0) 83
Secondary 56.3 % (49.5–62.9) 116 52.8 % (45.0–60.5) 145 32.1 % (26.3–38.5) 125
Above secondary 13.6 % (8.6–20.9) 28 13.3 % (8.4–20.5) 32 7.1 % (3.8–12.9) 26
Monthly income (USD)d
Weighted median (IQR) 43 USD (0–109) 40 USD (0–121) 20 USD (0–60)
aWeighted estimates, adjusted for survey design with sampling weights applied. See Additional file 1 on sampling methods for more details; bactual number of
respondents, without sampling weights applied; cdata missing for 3 participants from Mwanza municipality, 20 from district towns and for 39 rural participants;
dMissing for 1 participant from Entebbe municipality and 2 rural participants. CI, confidence interval; IQR, interquartile range
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Table 2 Population prevalence of risk factors for NCDs among men (≥18 years)
Tanzania – Total men Mwanza municipality
(number = 77)
District towns
(number = 153)
Rural (number = 275)
Weighted %
(95 % CI)a
Unweighted
Nb
Weighted %
(95 % CI)a
Unweighted
Nb
Weighted %
(95 % CI)a
Unweighted
Nb
Smoking
Current smoker 18.6 % (7.9–38.0) 14 14.8 % (8.2–25.1) 23 22.7 % (17.1–29.5) 64
Ex–smoker 8.7 % (3.4–20.5) 6 16.3 % (8.6–28.7) 23 15.6 % (11.7–20.4) 45
Never smoked 72.7 % (54.4–85.6) 57 68.9 % (58.9–77.5) 107 61.7 % (54.4–68.5) 166
Alcohol consumption
Never drinks 58.8 % (51.3–65.9) 46 49.6 % (41.0–58.2) 77 54.8 % (48.2–61.3) 148
No drinking in past 12 months 12.7 % (8.7–18.3) 10 24.2 % (18.0–31.8) 36 30.0 % (25.1–35.3) 86
Drinking in past 12 months 28.5 % (23.1–34.5) 21 26.2 % (18.6–35.6) 40 15.2 % (11.8–19.4) 41
AUDIT scale (among drinkers)c
Non problem drinking 48.4 % (35.6–61.4) 10 49.5 % (30.2–68.9) 19 61.1 % (44.6–75.4) 24
Problem drinking 51.6 % (38.6–64.4) 11 50.5 % (31.1–69.8) 20 38.9 % (24.6–55.4) 17
Eats fewer than one serving of fruit/
vegetables per dayd
28.9 % (20.0–39.7) 17 28.0 % (19.2–39.0) 31 40.1 % (31.5–49.5) 78
Eats fruit/vegetables fewer than 5 days/week 25.3 % (17.9–34.3) 20 24.3 % (17.5–32.8) 38 33.8 % (24.6–44.5) 86
Days of vigorous physical activity/weeke
None 29.8 % (19.1–43.1) 25 35.0 % (27.8–42.9) 53 21.3 % (16.9–26.5) 59
1–2 7.0 % (2.6–17.7) 7 7.9 % (4.6–13.2) 12 6.4 % (3.6–11.2) 19
3–4 11.0 % (3.9–27.4) 8 7.5 % (4.3–13.0) 12 8.1 % (5.2–12.3) 23
5+ 52.3 % (35.6–68.5) 37 49.6 % (39.0–60.3) 76 64.2 % (59.0–69.0) 174
BMI category (kg/m2)f
Underweight (<18.5) 15.5 % (9.6–24.1) 11 7.0 % (3.5–13.7) 10 17.2 % (12.7–23.0) 44
Normal (18.5– < 25) 71.1 % (63.5–77.7) 54 78.3 % (70.8–84.3) 120 77.6 % (72.4–82.1) 214
Overweight (25– < 30) 8.4 % (4.4–15.5) 6 8.0 % (4.7–13.3) 12 4.3 % (2.0–9.0 ) 13
Obese (≥30) 5.0 % (2.3–10.4) 4 6.7 % (3.1–13.6) 10 0.8 % (0.2–3.3 ) 2
Waist circumference >94 cmf 10.6 % (4.4–23.1) 8 13.4 % (8.1–21.4) 20 1.6 % (0.7–3.9 ) 5
Uganda– Total men Entebbe municipality (number = 79) District towns (number = 108) Rural (number = 188)
Smokingg
Current smoker 17.7 % (8.6–33.1) 14 12.2 % (6.3–22.3) 10 17.4 % (11.6–25.4) 33
Ex–smoker 15.2 % (8.9–24.8) 12 11.0 % (6.1–19.0) 12 16.0 % (11.7–21.6) 30
Never smoked 67.1 % (52.8–78.8) 53 76.8 % (63.8–86.2) 85 66.5 % (56.2–75.5) 125
Alcohol consumption
Never drinks 26.6 % (16.7–39.6) 21 44.8 % (35.7–54.1) 43 28.7 % (21.1–37.8) 52
No drinking in past 12 months 15.2 % (7.6–27.9) 12 22.0 % (12.9–35.0) 25 20.5 % (15.9–26.0) 42
Drinking in past 12 months 58.2 % (44.0–71.2) 46 33.2 % (23.5–44.6) 40 50.8 % (41.6–60.0) 94
AUDIT scale (among drinkers)h
Non problem drinking 80.0 % (70.1–87.2) 36 86.5 % (71.7–94.1) 37 88.1 % (75.2–94.8) 83
Problem drinking 20.0 % (12.8–29.9) 9 13.5 % (5.9–28.3) 3 11.9 % (5.2–24.8) 11
Eats fewer than one serving of fruit/
vegetables per day
41.8 % (29.8–54.7) 33 59.9 % (51.9–67.4) 70 70.0 % (61.8–77.0) 135
Eats fruit/vegetables fewer than 5 days/week 39.2 % (28.4–51.2) 31 60.9 % (53.8–67.5) 65 58.0 % (47.9–67.4) 114
Days of vigorous physical activity/weeke
None 59.5 % (52.4–66.2) 47 68.8 % (56.0–79.3) 75 72.5 % (63.7–79.8) 140
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in Entebbe municipality, 278 in district towns and 432 in
rural communities, resulting in a total of 916 partici-
pants from 435 households. Assuming that the numbers
of people within households that did not participate in
the survey were similar to those that did, we estimate
that we enrolled about 72 % of the targeted study popu-
lation in Tanzania and 68 % in Uganda. The median age
of the study sample was highest in rural areas in both
Tanzania and Uganda (33 years, interquartile range
(IQR) 24 to 49 and 35 years, IQR 24 to 49, respectively;
Table 1). Women made up a larger proportion of the
study sample in all strata in both countries (52 % to
62 %), and this difference was largest in Entebbe town.
In Tanzania, a higher proportion (56 % to 71 %) of
study participants were married than in Uganda (45 % to
55 %), and this proportion was higher in rural than
urban areas. The level of education varied, with small
proportions having received post-secondary education,
and 40 % to 50 % of participants from rural areas in both
countries not having completed primary education. Par-
ticipants from Uganda reported completion of secondary
education more often than those from Tanzania (32 % to
56 % versus 8 % to 27 %). The median individual
monthly monetary income was 38 to 43 US dollars
(US$), 40 to 57 USD and 19 to 20 USD in municipal
areas, district towns and rural areas, respectively, and
was similar across countries except for district towns in
Tanzania from where the highest median income was re-
ported (57 USD).
Prevalence of risk factors for NCDs
The proportion of current smokers among men was
substantially higher than among women (12 % to 23 %
versus 1 % to 3 %) (Tables 2 and 3), and was consistently
higher in Tanzania than in Uganda, while there was no
clear trend across countries among women. In both
countries, over 60 % of men and over 90 % of women
had never smoked. The proportion who reported drink-
ing alcohol during the past 12 months was also higher
among men than women (15 % to 29 % versus 4 % to
14 % in Tanzania; 33 % to 58 % versus 29 % to 35 % in
Uganda), and was higher in Uganda than in Tanzania for
both men and women. The prevalence of problem drink-
ing based on the AUDIT scale ranged across strata from
6 % to 15 % among men in Tanzania and 6 % to 12 % in
Uganda; and from 1 % to 6 % among women in Tanzania
and from 1 % to 2 % in Uganda.
A substantial proportion of the population reported eat-
ing fruit or vegetables on fewer than five days per week:
20 % to 34 % in Tanzania and 39 % to 61 % in Uganda.
The low intake of fruit was similar among men and
women, and was observed in both urban and rural areas.
A large proportion of the population, ranging from 21 %
among rural men in Tanzania to 96 % among women
from Ugandan district towns, reported no regular vigor-
ous physical activity. This risk factor was more common
in Uganda than Tanzania, among women than men in
both countries, and in urban areas in Tanzania (but not
Uganda). The majority of the population in both countries
had a normal BMI, but many were overweight or obese
(BMI ≥25 kg/m2), ranging from 5 % among rural Tanza-
nian men to 46 % among women in district towns in
Uganda. Women were more affected than men in all
strata. Waist circumference measurements generally mir-
rored these proportions. Despite the high prevalence of
overweight, there was also a significant prevalence of mal-
nutrition (BMI <18.5 kg/m2) in all areas (0.4 % to 17 %).
Malnutrition was more prevalent in rural than urban
areas, and in Tanzania than in Uganda, and was similar
among men and women (Tables 2 and 3).
Table 2 Population prevalence of risk factors for NCDs among men (≥18 years) (Continued)
1–2 12.7 % (4.8–29.2) 10 9.3 % (4.3–18.8) 9 4.2 % (1.6–10.6) 7
3–4 10.1 % (5.6–17.6) 8 0.4 % (0.1–1.1 ) 4 6.0 % (3.1–11.5) 11
5+ 17.7 % (7.5–36.3) 14 21.5 % (11.8–36.1) 20 17.3 % (11.3–25.5) 30
BMI category (kg/m2)i
Underweight (<18.5) 2.6 % (0.7–8.8 ) 2 8.1 % (3.3–18.7) 9 16.0 % (10.6–23.4) 30
Normal (18.5– < 25) 85.7 % (75.1–92.3) 66 71.4 % (60.2–80.5) 80 74.8 % (67.6–80.9) 142
Overweight (25– < 30) 9.1 % (3.0–24.3) 7 14.2 % (7.6–25.0) 12 8.5 % (4.8–14.7) 15
Obese (≥30) 2.6 % (0.7–9.0 ) 2 6.3 % (3.0–12.8) 5 0.7 % (0.1–4.7 ) 1
Waist circumference >94 cmi 7.6 % (3.1–17.7) 6 15.6 % (9.2–25.2) 12 3.5 % (1.5–8.0 ) 6
aWeighted estimates, adjusted for survey design with sampling weights applied. See footnote 1 of Table 1; bactual number of respondents, without sampling
weights applied; cmissing for 1 participant from district towns. dmissing for 14 participants from Mwanza municipality, 42 from district towns and for 82 rural
participants (majority did not recall how many servings of vegetables they ate); edefined as spending at least 10 minutes continuously in vigorous–intensity
activity per day (as per WHO STEPS Survey questionnaire); fBMI missing for 2 participants from Mwanza municipality, 1 from district towns and for 2 rural
participants. Waist circumference data missing for 1 participant from Mwanza municipality; gsmoking data missing for 1 participant from Entebbe municipality;
hAUDIT score missing for 1 participant from Entebbe municipality; iBMI data missing for 2 participants from Entebbe municipality and 2 from district towns. Waist
circumference data missing for 2 participants from district towns. AUDIT, Alcohol Use Disorders Identification Test; BMI, body mass index; CI, confidence interval;
NCDs, non-communicable diseases
Kavishe et al. BMC Medicine  (2015) 13:126 Page 7 of 21
Table 3 Population prevalence of risk factors for NCDs among women (≥18 years)
Tanzania– Total women Mwanza municipality (number = 98) District towns (number = 191) Rural (number = 301)
Weighted %
(95 % CI)a
Unweighted Nb Weighted %
(95 % CI)a
Unweighted Nb Weighted %
(95 % CI)a
Unweighted Nb
Smoking
Current smoker 2.9 % (0.8–10.0) 3 1.3 % (0.3–6.3 ) 3 1.2 % (0.3–5.1 ) 3
Ex–smoker 3.5 % (1.2–9.7 ) 3 1.1 % (0.3–4.2 ) 2 1.3 % (0.5–3.4 ) 4
Never smoked 93.6 % (85.4–97.3) 92 97.6 % (93.5–99.1) 186 97.6 % (94.9–98.9) 294
Alcohol consumption
Never drinks 75.2 % (61.7–85.1) 75 66.4 % (58.6–73.4) 128 76.5 % (68.7–82.8) 231
No drinking in past 12 months 11.2 % (6.2–19.3) 11 24.2 % (18.5–30.9) 44 19.1 % (13.2–26.9) 59
Drinking in past 12 months 13.6 % (6.2–27.1) 12 9.4 % (5.8–14.8) 19 4.4 % (2.5–7.4 ) 11
AUDIT scale (among drinkers)c
Non problem drinking 58.6 % (30.8–81.8) 7 78.6 % (59.2–90.3) 14 72.4 % (41.2–90.8) 8
Problem drinking 41.4 % (18.2–69.2) 5 21.4 % (9.7–40.8) 4 27.6 % (9.2–58.8) 3
Eats fewer than one serving of
fruit/vegetables per dayd
27.9 % (16.0–44.0) 26 22.3 % (14.1–33.3) 35 34.8 % (24.7–46.5) 75
Eats fruit/vegetables fewer than
5 days/week
31.0 % (18.8–46.7) 31 19.7 % (12.4–29.9) 40 25.7 % (18.0–35.1) 72
Days of vigorous physical
activity/weeke,f
None 59.6 % (48.2–70.1) 58 65.7 % (56.8–73.7) 127 34.0 % (27.4–41.2) 103
1–2 4.9 % (1.9–12.1) 5 5.5 % (3.3–9.0 ) 10 3.2 % (2.0–5.2 ) 10
3–4 5.4 % (2.0–13.8) 5 3.7 % (1.7–7.7 ) 7 9.3 % (5.8–14.5) 28
5+ 30.1 % (21.2–40.6) 29 25.1 % (17.6–34.5) 47 53.5 % (45.2–61.7) 160
BMI category (kg/m2) g,h
Underweight (<18.5) 10.8 % (7.2–16.0) 11 7.4 % (4.1–13.2) 14 9.8 % (6.7–14.1) 25
Normal (18.5– < 25) 56.1 % (47.4–64.5) 53 53.3 % (45.7–60.7) 98 74.4 % (68.1–79.9) 204
Overweight (25– < 30) 24.0 % (17.9–31.5) 22 17.6 % (13.2–23.1) 32 12.8 % (8.8–18.1) 37
Obese (≥30) 9.0 % (4.9–15.9) 9 21.7 % (14.3–31.6) 38 3.0 % (1.2–7.3 ) 8
Waist circumference >80 cmg 40.2 % (30.6-50.6) 37 47.5 % (38.6-56.5) 85 32.4 % (26.4-39.1) 93
Uganda– Total women Entebbe municipality (n = 127) District towns (n = 170) Rural (n = 244)
Smoking
Current smoker 1.6 % (0.4–5.7 ) 2 3.3 % (1.1–9.0 ) 5 2.1 % (0.9–4.9 ) 6
Ex–smoker 3.9 % (1.5–9.6 ) 5 1.1 % (0.2–6.8 ) 2 4.1 % (2.3–7.3 ) 9
Never smoked 94.5 % (87.3–97.7) 120 95.6 % (90.4–98.1) 163 93.7 % (89.3–96.4) 229
Alcohol consumption
Never drinks 36.2 % (27.4–46.0) 46 46.1 % (37.0–55.5) 78 45.9 % (38.4–53.6) 115
No drinking in past 12 months 28.3 % (18.3–41.1) 36 23.0 % (16.5–31.0) 38 25.6 % (18.1–34.8) 61
Drinking in past 12 months 35.4 % (25.0–47.5) 45 30.9 % (26.8–35.3) 54 28.5 % (20.6–37.8) 68
AUDIT scale (among drinkers)
Non problem drinking 97.8 % (83.6–99.7) 44 96.6 % (81.5–99.5) 53 94.5 % (84.2–98.2) 64
Problem drinking 2.2 % (0.3–16.4) 1 3.4 % (0.5–18.5) 1 5.5 % (1.8–15.8) 4
Eats fewer than one serving of
fruit/vegetables per day
46.5 % (36.0–57.2) 59 58.1 % (48.6–67.1) 112 63.5 % (54.6–71.5) 158
Eats fruit/vegetables fewer than
5 days/week
44.9 % (35.3–54.8) 57 43.0 % (33.3–53.2) 90 51.2 % (44.0–58.4) 128
Kavishe et al. BMC Medicine  (2015) 13:126 Page 8 of 21
Prevalence of chronic diseases
In both countries and across all strata, hypertension was
the most common NCD (Table 4). Hypertension preva-
lence was highest in rural areas (17 % in Tanzania and
26 % in Uganda), but was only slightly lower in munici-
pal areas and district towns. Overall, only 6 % of individ-
uals with hypertension in each country reported that
they were taking medication for their condition, with the
lowest proportion in rural Tanzania (3 %). In both coun-
tries, even among those on treatment, hypertension was
not controlled in the majority. Between 5 % and 9 % of
the study population had stage II hypertension.
Hypertension was more prevalent in older age groups,
yet a substantial proportion of people aged under 25-
years had hypertension (for example, 6 % to 19 % and
7 % to 17 % of young men in Tanzania and Uganda, re-
spectively), although confidence intervals were wide
(Table 5).
The prevalence of DM was around 1 % to 2 % across
all strata in Tanzania, and slightly higher in Uganda (2 %
to 4 %) (Table 4). Of the 33 participants with DM, 27/33
(82 %) were diagnosed based on elevated RBG and FBG
levels, one had high RBG (with no FBG measurement)
and five (15 %) had normal RBG levels, but reported to
be on diabetes medication. Another 11 received medica-
tion but were not controlled (69 % of those on treat-
ment). Across strata, between 38 % and 70 % of patients
in Tanzania, and between 40 % and 80 % in Uganda were
aware of their diabetic condition, with lower levels in
rural than urban areas.
Heart failure prevalence ranged from about 1 % in
Tanzanian district towns to 9 % in Entebbe town, with no
clear trends by area. The prevalence of obstructive lung
disease ranged from 3 % in Tanzanian district towns to
10 % in rural Uganda and was highest in rural areas in
both countries. Epilepsy was reported by only a few partic-
ipants, mostly from rural Tanzania (prevalence 1.6 %).
With the exception of DM, the proportion of the
population with CDs who were aware of their condition
was low, and this lack of awareness was more prevalent
in rural areas. For example, 80 % and 93 % of the popu-
lation with hypertension in rural Uganda and Tanzania,
respectively, were not aware of their condition, com-
pared with 65 % and 70 % in Mwanza and Entebbe mu-
nicipalities, respectively.
HIV prevalence for both sexes combined ranged from
6 % (95 % CI 4 % to 11 %) in rural areas to 10 % (CI 6 %
to 16 %) in district towns in Tanzania, and from 6 % (CI
2 % to 12 %) in district towns to 12 % (CI 9 % to 16 %) in
Entebbe municipality in Uganda (Table 4). It was higher
among women than men in all strata, and this difference
was particularly strong in municipal areas and district
towns in both countries (Fig. 2). Among the HIV positive
population, awareness was also low, ranging from 6 % in
Mwanza to 35 % in district towns in Tanzania, and from
26 % in district towns to 52 % in rural areas in Uganda.
Age-standardized CD prevalences were generally higher
than the observed population prevalences for most condi-
tions (Fig. 2 versus Fig. 3), reflecting the fact that the
prevalence of these CDs increases with age, and that the
Tanzanian and Ugandan populations are somewhat youn-
ger than the average world population. For example, age-
standardized hypertension prevalence was 19 % to 25 %
among men and 20 % to 25 % among women from
Tanzania and 27 % to 44 % among men and 19 % to
32 % among women in Uganda (Fig. 2), while the
Table 3 Population prevalence of risk factors for NCDs among women (≥18 years) (Continued)
Days of vigorous physical
activity/weeke
None 81.9 % (64.7–91.8) 104 95.6 % (89.4–98.2) 162 91.9 % (84.0–96.1) 225
1–2 7.9 % (3.0–19.3) 10 1.1 % (0.1–8.0 ) 2 3.1 % (1.4–6.6 ) 7
3–4 2.4 % (0.5–9.6 ) 3 2.2 % (0.6–7.5 ) 3 0.5 % (0.1–4.0 ) 1
5+ 7.9 % (3.2–18.1) 10 1.2 % (0.2–8.0 ) 3 4.5 % (1.9–9.9 ) 11
BMI category (kg/m2)i,j
Underweight (<18.5) 1.7 % (0.4–6.2 ) 2 0.4 % (0.1–0.9 ) 5 10.0 % (6.3–15.5) 26
Normal (18.5– < 25) 55.4 % (42.5–67.5) 67 54.1 % (45.0–63.0) 83 48.2 % (38.7–57.9) 114
Overweight (25– < 30) 24.8 % (17.2–34.4) 30 30.1 % (23.9–37.1) 46 30.3 % (23.6–38.0) 63
Obese (≥30) 18.2 % (9.9–31.0) 22 15.4 % (11.1–21.1) 21 11.4 % (7.4–17.2) 24
Waist circumference >80 cmk 39.8 % (26.4–55.0) 49 41.9 % (33.2–51.1) 68 44.6 % (37.9–51.6) 95
aWeighted estimates, adjusted for survey design with sampling weights applied. See footnote 1 of Table 1; bactual number of respondents, without sampling
weights applied; cmissing for 1 participant from district towns; dmissing for 10 participants from Mwanza municipality, 39 from district towns and 78 rural
participants (majority did not recall how many servings of vegetables they ate); edefined as spending at least 10 minutes continuously in vigorous–intensity
activity per day (as per WHO STEPS Survey questionnaire); fmissing for 1 participant from Mwanza municipality; gBMI and waist circumference results exclude 35
pregnant women; hmissing for 4 rural participants; iBMI and waist circumference results exclude 33 pregnant women; jmissing for 3 participants from Entebbe
municipality, 1 from district towns and 1 rural participant. kmissing for 1 participant from Entebbe municipality. AUDIT, Alcohol Use Disorders Identification Test;
BMI, body mass index; CI, confidence interval; NCDs, non-communicable diseases
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Table 4 Population prevalence of chronic disease (≥18 years) and proportion aware of condition
Tanzania – Total respondents Mwanza municipality
(number = 175)
District towns
(number = 344)
Rural
(number = 576)
Weighted %
(95 % CI)a
Unweighted
Nb
Weighted %
(95 % CI)a
Unweighted
Nb
Weighted %
(95 % CI)a
Unweighted
Nb
HIV positivec 9.1 % (5.3–15.3) 15 10.3 % (6.5–15.8) 35 6.4 % (3.7–10.9) 37
Previously diagnosedd 6.0 % (0.9–30.0) 1 34.5 % (16.9–57.7) 12 32.4 % (20.4–47.2) 12
On treatmente 6.0 % (0.9 -30.0) 1 25.8 % (11.6-48.0) 9 28.7 % (17.1-44.0) 11
Hypertensionf 16.4 % (11.7–22.4) 29 16.8 % (12.6–21.9) 56 17.6 % (13.9–21.9) 107
Previously diagnosed, on
treatment and controlledd,g,h
3.7 % (0.6–18.5) 1 1.7 % (0.2–10.9) 1 0 0
Previously diagnosed, on
treatment and not controlledd,g,h
7.6 % (2.0–24.6) 2 5.4 % (1.5–17.6) 3 2.5 % (0.7–8.7 ) 2
Previously diagnosed and not on
treatmentd,h
23.6 % (14.5–35.9) 7 10.4 % (4.7–21.6) 6 4.4 % (1.8–10.6) 4
No previous diagnosish 65.2 % (50.4–77.6) 19 82.5 % (69.0–90.9) 46 93.1 % (82.9–97.4) 101
Stage I i 6.0 % (3.5–10.1) 11 10.7 % (7.4–15.3) 35 12.1 % (9.6–15.1) 74
Stage II i 8.8 % (5.1–14.8) 15 5.0 % (2.8–8.9 ) 17 5.1 % (3.2–7.9 ) 31
Diabetesj,k 1.9 % (0.7–5.0 ) 3 1.5 % (0.6–3.6 ) 5 0.6 % (0.1–2.8 ) 3
Previously diagnosedd 70.1 % (14.5–97.0) 2 82.4 % (40.3–97.0) 4 37.7 % (16.3–65.2) 1
On treatmente 70.1 % (14.5–97.0) 2 41.2 % (7.8 -85.3) 2 37.7 % (16.3-65.2) 1
Heart failurel 3.3 % (1.7–6.4 ) 6 1.4 % (0.8–2.5 ) 5 4.5 % (3.2–6.2 ) 22
Previously diagnosedd 21.2 % (2.3–75.8) 1 0 0 0 0
COPD/asthmam,n 3.5 % (1.5–7.9 ) 6 2.7 % (1.3–5.7 ) 9 3.9 % (2.2–6.9 ) 25
Previously diagnosedd 0 0 11.8 % (1.3 -58.0) 1 8.5 % (2.2 -27.3) 2
On treatmente 0 1 11.8 % (1.3 -58.0) 1 3.6 % (0.6 -19.8) 1
Epilepsyo 0.6 % (0.1–3.8 ) 1 0.8 % (0.3–2.2 ) 3 1.6 % (0.7–3.4 ) 8
Any CD (NCDs and HIV infection) 29.5 % (20.2-40.9) 52 28.0 % (21.7-35.2) 95 29.1 % (25.1-33.4) 172
More than one CD 4.7 % (2.3 -9.4 ) 8 4.7 % (2.5 -8.5 ) 17 4.1 % (2.3 -7.2 ) 25
Any NCD 22.6 % (15.3-32.1) 40 20.8 % (15.3-27.7) 70 25.0 % (21.3-29.1) 148
More than one NCD 2.9 % (1.3 -6.2 ) 5 2.0 % (1.0 -4.0 ) 7 2.8 % (1.4 -5.4 ) 16
Uganda - Total respondents Entebbe municipality
(number = 206)
District towns
(number = 278)
Rural
(number = 432)
HIV positivec 12.2 % (9.4–15.7) 25 5.5 % (2.4–12.4) 24 11.6 % (8.0–16.6) 49
Previously diagnosedd 40.0 % (22.5–60.5) 10 26.4 % (8.0–59.5) 8 51.9 % (34.8–68.5) 25
On treatmente 36.0 % (19.5-56.6) 9 26.4 % (8.0 -59.5) 8 49.3 % (33.2-65.6) 24
Hypertensionf 22.3 % (16.2–30.0) 46 19.2 % (14.0–25.6) 49 26.3 % (23.0–29.9) 111
Previously diagnosed, on
treatment and controlledd,g,h
2.2 % (0.3–15.4) 1 3.4 % (0.5–20.8) 2 3.4 % (0.9–12.2) 3
Previously diagnosed, on
treatment and not controlledd,g,h
13.0 % (4.0–34.9) 6 12.8 % (4.3–32.3) 4 5.1 % (2.4–10.5) 5
Previously diagnosed and not on
treatmentd,h
15.2 % (7.4–28.9) 7 6.4 % (1.6–22.2) 2 11.9 % (7.1–19.2) 12
No previous diagnosish 69.6 % (52.0–82.8) 32 77.3 % (59.2–88.9) 41 79.7 % (74.6–84.0) 91
Stage I i 12.1 % (7.3–19.3) 24 11.1 % (7.7–15.9) 26 16.9 % (14.3–19.9) 68
Stage II i 7.5 % (4.6–12.0) 15 5.4 % (2.8–10.4) 17 7.8 % (5.4–11.0) 35
Diabetesj,p 2.4 % (0.9–6.2 ) 5 3.8 % (1.8–7.8 ) 7 3.0 % (1.4–6.2 ) 10
Previously diagnosedd 80.0 % (34.6–96.8) 4 67.0 % (15.4–95.8) 5 40.0 % (22.3–60.8) 4
On treatmente 80.0 % (34.6-96.8) 4 50.5 % (11.9-88.5) 4 30.0 % (15.2-50.6) 3
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corresponding observed prevalences were 18 % to 18 %
among men and 14 % to 17 % among women from
Tanzania, and 25 % to 30 % among men and 11 % to 27 %
among women from Uganda (Fig. 3).
Across different strata, between 21 % and 37 % of the
survey population had any NCD, and between 2 % and
6 % had more than one NCD (Table 4). This comorbid-
ity occurred more often in Uganda than Tanzania, but
there were no systematic differences between strata. The
prevalence of diabetes was about four times higher
among patients with hypertension than overall, and
about two thirds of the patients with diabetes were also
hypertensive (data not shown).
Factors associated with hypertension
Among the socio-demographic variables, age, sex, marital
status and education were independently associated with
hypertension (Table 6). Hypertension prevalence increased
significantly with age: adjusted odds ratio (aOR) = 10.30,
95 % CI 6.41 to 16.54, comparing those ≥45-years old with
those <25-years old; decreasing education level (aOR =
1.40, 95 % CI 0.95 to 2.05, comparing those with less than
primary to those with secondary or above), and with being
divorced, separated or widowed (aOR = 1.49, CI = 1.11 to
2.00, compared with those who were married). Hyperten-
sion prevalence was significantly lower among women
than men (aOR 0.67, 95 % CI 0.53 to 0.86).
Among behavioral risk factors, after adjusting for
stratum and socio-demographic risk factors, hyperten-
sion prevalence was lower among ex-smokers (aOR 0.56,
95 % CI 0.38 to 0.82) and current smokers (aOR 0.51,
95 % CI 0.35 to 0.77) than never-smokers (P <0.001)
(Table 6). In the crude analysis (adjusted for sampling
stratum only), there was no evidence of an association
between smoking and hypertension, but after adjusting
for age and sex, the strong inverse association appeared.
There was no significant association of hypertension
with other behavioral risk factors.
Among anthropometric risk factors, after adjusting for
stratum and socio-demographic and behavioral risk fac-
tors, both higher BMI and a waist circumference above
normal range were associated with hypertension. Partici-
pants with a high waist circumference had a two-fold
higher odds of hypertension compared with those with
normal waist circumference (aOR = 1.83, 95 % CI 1.12
to 3.01).
In an analysis of factors associated with untreated
stage II hypertension, we observed generally similar di-
rections of associations including weak evidence of an
inverse association with smoking (Table 7). An analysis
restricted to patients with hypertension showed that
women were two-fold more likely than men to develop
stage II hypertension. While men were overall more
likely to be hypertensive (Table 6), women were more
Table 4 Population prevalence of chronic disease (≥18 years) and proportion aware of condition (Continued)
Heart failurel 9.2 % (5.5–15.1) 19 2.6 % (1.1–5.9 ) 7 3.0 % (1.5–6.0 ) 12
Previously diagnosedd 5.3 % (0.7–30.9) 1 23.9 % (2.7–78.3) 1 0 0
COPD/asthmam,q 3.5 % (1.9–6.3 ) 7 2.2 % (0.9–5.1 ) 11 9.6 % (6.2–14.4 ) 41
Previously diagnosedd 0 0 0 0 3.3 % (0.5–18.3 ) 1
On treatmente 0 0 0 0 3.3 % (0.5–18.3 ) 1
Epilepsyo,r 0 0 0 0 1.1 % (0.3–3.3 ) 5
Any CD (NCDs and HIV infection) 39.3 % (35.4-43.4) 81 28.6 % (22.3-35.8) 84 44.7 % (38.9-50.6) 189
More than one CD 7.3 % (5.5 -9.6 ) 15 4.5 % (2.3 -8.4 ) 12 8.9 % (6.3 -12.4) 38
Any NCD 31.1 % (26.7-35.8) 64 23.8 % (17.9-30.9) 64 36.7 % (32.8-40.8) 156
More than one NCD 5.3 % (3.5 -8.0 ) 11 3.8 % (1.8 -7.8 ) 9 5.6 % (3.6 -8.6 ) 23
aWeighted estimates, adjusted for survey design with sampling weights applied. See footnote 1 of Table 1; bactual number of respondents, without sampling
weights applied; 3HIV diagnosis missing for 8 participants from Mwanza municipality, 1 from Entebbe municipality, and for 1 rural participant in Uganda (majority
refused blood test); dparticipants reported having been told by a doctor in the past 12 months that they have the condition; denominator is those diagnosed with
the condition during the survey; eparticipants reported currently receiving medication for the condition; denominator is those diagnosed with the condition
during the survey; fsystolic BP ≥140 and/or diastolic BP ≥90, in 3rd measurement at a single visit, or currently receiving drugs for high blood pressure. Missing for
1 participant from Mwanza municipality and 1 rural participant in Tanzania; gparticipants reported currently receiving drugs for high blood pressure; ‘controlled’
defined as systolic BP <140 and diastolic BP <90); hdenominator is N with hypertension; istage I: systolic BP ≥140 and <160 and/or diastolic BP ≥90 and <100.
Stage II: systolic BP ≥160 and/or diastolic BP ≥100. Excludes participants currently receiving drugs for high blood pressure: 21 in Uganda and 9 Tanzania; jrandom
blood glucose (RBG) >11.1, or RBG 7 to 11.1 and fasting blood glucose (FBG) ≥7 mmol/L, or currently receiving insulin or oral diabetes drugs in the last two
weeks; kmissing for 3 participants from Mwanza municipality, 7 from district towns and for 12 rural participants (majority refused RBG or did not return for FBG
test); lorthopnea or paroxysmal nocturnal dyspnea (PND) and at least 2/3 of edema, breathlessness on excersion (BOE) and heart rate (HR) >120, or orthopnea and
PND and at least 1/3 of edema, BOE and HR >120; mFEV1/FVC <0.70; nCOPD/asthma diagnosis missing for 4 participants from Mwanza municipality, 8 from district
towns and for 17 rural participants (mostly because test was contraindicated or participant unable to perform test); oreports having had a seizure in past
12 months, or currently taking medication for epilepsy; pmissing for 1 participant from district towns and for 2 rural participants; qCOPD/asthma diagnosis missing
for 4 participant from Entebbe municipality, 9 from district towns and for 30 rural participants (majority were unable to perform the spirometry test); rmissing for
one participant from Entebbe municipality. BP, blood pressure; CD, chronic disease; CI, confidence interval; COPD, chronic obstructive pulmonary disease; NCD,
non-communicable disease
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likely to develop advanced disease (see Supplementary
table in Additional file 2).
An analysis of the small group of hypertensive patients
who were aware of their condition suggests that older
people, women and those with a comparatively higher in-
come were more likely to know their diagnosis. Awareness
was more common among ex smokers, but also among
those who were less physically active and being overweight.
The adjusted PAF of hypertension due to overweight
and obesity was 13 %, and for central obesity (defined by
waist circumference above the normal range) was 18 %.
The adjusted joint PAF of hypertension for both risk fac-
tors was 28 %.
Discussion
In this population-based survey in northwestern Tanzania
and southern Uganda, we observed a high prevalence of
hypertension: in different strata the age-standardized
prevalence ranged between 19 % and 25 % in Tanzania
and between 19 % and 44 % in Uganda, consistent with
other studies from sub-Saharan Africa [23–26]. The prev-
alences of other NCDs were comparatively low. Risk fac-
tors for NCDs were also common in both countries,
although their prevalence varied between men and
women, with smoking and alcohol consumption being
more prevalent among men, while obesity and reported
lack of physical activity occurred more frequently among
women. Obesity was particularly common, exceeding
15 % among women in some strata. Age-standardized
HIV prevalence was high and consistent with data from
national statistics in both countries [27, 28].
Hypertension prevalence was higher in rural than
urban areas, in contrast to a 2007 review [23], but in line
with some more recent studies [29–31]. This is
Table 5 Prevalence of hypertensiona by sex and age group
Municipality (Mwanza /Entebbe) District towns Rural
Weighted % (95 % CI)b Unweighted Nc Weighted % (95 % CI)b Unweighted Nc Weighted % (95 % CI)b Unweighted Nc
Tanzania
Men
Age group
18–24 years 5.7 % (0.9 -29.9) 1 / 22 19.2 % (10.2-33.2) 8 / 42 8.1 % (2.6 -22.7) 5 / 65
25–34 years 5.4 % (1.0 -23.7) 2 / 28 4.2 % (1.1 -14.9) 2 / 55 20.5 % (15.1-27.2) 15 / 70
35–44 years 50.9 % (23.7-77.6) 6 / 11 34.6 % (19.7-53.3) 10 / 30 15.6 % (8.8 -25.9) 8 / 51
≥45 years 35.9 % (18.0-58.7) 6 / 15 37.2 % (20.9-57.0) 9 / 26 25.0 % (16.1-36.5) 26 / 88
Women
Age group
18–24 years 3.4 % (0.7 -14.5) 1 / 31 1.8 % (0.2 -11.8) 1 / 68 4.1 % (1.7 -9.8 ) 4 / 80
25–34 years 7.6 % (1.9 -25.6) 2 / 29 6.7 % (2.6 -15.9) 5 / 75 9.0 % (4.2 -18.0) 7 / 86
35–44 years 21.2 % (7.9 -45.9) 4 / 18 29.2 % (15.2-48.7) 6 / 22 7.1 % (2.5 -18.8) 4 / 42
≥45 years 36.3 % (20.2-56.2) 7 / 20 58.0 % (40.5-73.7) 15 / 26 41.4 % (27.7-56.6) 38 / 93
Uganda
Men
Age group
18–24 years 7.4 % (1.7 -26.9) 2 / 27 16.9 % (7.6 -33.2) 4 / 35 17.4 % (8.6 -32.0) 7 / 45
25–34 years 26.7 % (12.2-48.7) 8 / 30 14.4 % (6.8 -27.9) 3 / 34 8.6 % (3.0 -22.4) 4 / 45
35–44 years 44.4 % (18.9-73.3) 4 / 9 41.2 % (15.1-73.3) 6 / 19 21.1 % (9.3 -41.1) 7 / 31
≥45 years 76.9 % (58.6-88.7) 10 / 13 70.4 % (43.1-88.3) 12 / 20 44.9 % (33.5-56.7) 31 / 67
Women
Age group
18–24 years 2.9 % (0.4 -16.2) 1 / 35 2.8 % (0.5 -15.9) 2 / 59 6.0 % (2.5 -13.8) 3 / 60
25–34 years 7.0 % (2.0 -21.8) 3 / 43 9.9 % (3.6 -24.5) 5 / 53 16.2 % (7.1 -32.8) 7 / 50
35–44 years 26.1 % (10.8-50.6) 6 / 23 1.1 % (0.3 -4.3 ) 2 / 26 25.6 % (14.5-41.0) 10 / 47
≥45 years 46.2 % (33.1-59.8) 12 / 26 40.8 % (19.4-66.4) 15 / 32 50.5 % (37.8-63.1) 42 / 87
aSystolic BP ≥140 and/or diastolic BP ≥90, in 3rd measurement at a single visit, or currently receiving drugs for high blood pressure; bweighted estimates, adjusted
for survey design with sampling weights applied. See footnote 1 of Table 1; cactual number of respondents, without sampling weights applied. BP, blood
pressure; CI, confidence interval
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(A) Population of Mwanza and Entebbe municipalities
(B) District town population
(C) Rural population
Fig. 2 Chronic disease prevalence (age 18+ years), age-standardized to the WHO world population, for 3 study populations (a, Municipalities;
b, District towns; c Rural areas)
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(A) Population of Mwanza and Entebbe municipalities
(B) District town population
(C) Rural population
Fig. 3 Observed population prevalence of chronic diseases (age 18+ years) with 95 % confidence interval, for 3 study populations
(a, Municipalities; b, District towns; c Rural areas)
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Table 6 Factors associated with hypertensiona
Number with hypertension / total
Number (%)b
Age-, sex- and stratum adjusted OR
(95 % CI)c
Adjusted OR
(95 % CI)c,d
Sociodemographic
Age group P <0.001 P <0.001
18–24 years 39 / 569 (6.9 %) 1 1
25–34 years 63 / 598 (10.5 %) 1.61 (1.04 – 2.49) 1.62 (1.00 – 2.62)
35–44 years 73 / 329 (22.2 %) 4.04 (2.80 – 5.84) 4.01 (2.53 – 6.36)
≥45 years 223 / 513 (43.5 %) 11.23 (7.84 – 16.10) 10.30 (6.41 – 16.54)
Sex P = 0.008 P = 0.002
Male 196 / 878 (22.3 %) 1 1
Female 202 / 1131 (17.9 %) 0.72 (0.57 – 0.92) 0.67 (0.53 – 0.86)
Marital status P = 0.03 P = 0.02
Married/living as married 227 / 1205 (18.8 %) 1 1
Divorced/separated/widowed 125 / 351 (35.6 %) 1.52 (1.11 -2.07 ) 1.49 (1.11 -2.00 )
Single 46 / 453 (10.2 %) 1.22 (0.76 -1.96 ) 1.31 (0.81 -2.11 )
Education P = 0.06 P = 0.06
Secondary or above 91 / 675 (13.5 %) 1 1
Primary 135 / 651 (20.7 %) 1.62 (1.09 -2.40 ) 1.62 (1.09 -2.40 )
None/incomplete primary 172 / 683 (25.2 %) 1.45 (0.99 -2.13 ) 1.40 (0.95 -2.05 )
Monthly income (USD) P = 0.32 P = 0.44
Top tertile 119 / 655 (18.2 %) 1 1
Middle tertile 120 / 663 (18.1 %) 1.02 (0.71 -1.46 ) 0.96 (0.65 -1.40 )
Lower tertile 159 / 691 (23.0 %) 1.24 (0.90 -1.70 ) 1.16 (0.82 -1.64 )
Behavioral Adjusted OR (95 % CI)c,e
Smoking P = 0.004 P = 0.001
Never smoked 320 / 1676 (19.1 %) 1 1
Ex–smoker 37 / 153 (24.2 %) 0.59 (0.40 -0.87 ) 0.56 (0.38 -0.82 )
Current smoker 41 / 179 (22.9 %) 0.57 (0.38 -0.84 ) 0.51 (0.35 -0.77 )
Alcohol consumption P = 0.93 P = 0.59
Never drinks/no drinking in past
12 months
273 / 1518 (18.0 %) 1 1
Non–problem drinking7 100 / 399 (25.1 %) 1.00 (0.74 -1.36 ) 1.05 (0.76 -1.43 )
Problem drinking7 24 / 89 (27.0 %) 1.11 (0.63 -1.95 ) 1.36 (0.75 -2.46 )
Eats fruit/vegetables fewer than five
days/week
P = 0.69 P = 0.60
No 239 / 1238 (19.3 %) 1 1
Yes 159 / 771 (20.6 %) 1.05 (0.81 -1.37 ) 1.08 (0.82 -1.42 )
Days of vigorous physical activity/week P = 0.38 P = 0.32
None 255 / 1178 (21.6 %) 1.27 (0.89 -1.80 ) 1.29 (0.90 -1.85 )
1–4 35 / 221 (15.8 %) 1.08 (0.66 -1.77 ) 1.07 (0.65 -1.77 )
5+ 108 / 609 (17.7 %) 1 1
Anthropometric Adjusted OR (95 % CI)c,f
BMI category (kg/m2) P <0.001 P = 0.06
Underweight (<18.5) 29 / 191 (15.2 %) 0.57 (0.35 -0.93 ) 0.60 (0.37 -0.97 )
Normal (18.5– < 25) 217 / 1337 (16.2 %) 1 1
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consistent with the high prevalence of some NCD risk
factors in rural areas in our study, and suggests that life
style and dietary changes are increasingly affecting rural
areas in SSA. As expected, hypertension prevalence in-
creased with age, exceeding 40 % in several strata among
those ≥45 years old. However, hypertension was ob-
served even at comparatively young ages, particularly
among men, in agreement with some other studies in
SSA [32]. Being overweight increased the odds of being
hypertensive, as expected [33–35], with double the risk
for individuals with central obesity. However, the pro-
portion of cases of hypertension attributable to the joint
effect of obesity measured by BMI and waist circumfer-
ence was only 28 %; this contrasts with studies from
Europe and the US where two-thirds of hypertensive
cases were attributable to these factors [33, 36]. In
addition to behavioral and anthropometric risk factors,
other causes including salt sensitivity, subclinical renal
disease, chronic inflammation and/or genetic factors
may be playing a role in the pathogenesis of hyperten-
sion in our region [37–40]. Perhaps unexpectedly,
current smoking was associated with a lower risk of
hypertension; however, inconsistent or inverse associa-
tions between smoking and blood pressure have been
described by others [41, 42]. It is possible that the effect
is due to unrecorded or uncontrolled confounding
factors.
DM was much less common than hypertension, with an
overall observed prevalence of about 1 % in Tanzania and
3 % in Uganda. The prevalence in Tanzania is notably
lower than the 9 % prevalence observed in the recent
Tanzanian national STEPS survey [43]. This difference is
at least partly attributable to the different age bands in-
cluded (25 to 64 years compared to 18+ years as in our
study) and due to the inclusion of individuals with pre-
diabetes in the national survey (FBG ≥6.1 mmol/L com-
pared to ≥7 mmol/L as in our study). Diabetes prevalence
varies widely across SSA, from 1 % in rural Uganda to
12 % in urban Kenya [44]. The prevalence of heart failure
varied, with highest levels in Entebbe town (9 %) and
lowest in Tanzanian district towns (1 %). Hypertension is
the main cause of heart failure in Africa, and it may be
predicted that the prevalence and incidence of heart fail-
ure in Africa will rise due to the high burden of uncon-
trolled arterial hypertension [4, 45, 46].
We were not able to distinguish COPD from asthma
in this study as it was not possible to apply a broncho-
dilator before measuring FEV1 and FCV as is recom-
mended by the Global Initiative for Chronic Obstructive
Lung Disease [17]. In our study, using an age cut-off of
30 years and assuming that most COPD occurs above
this age, the prevalence of COPD would be between 1 %
and 6 % in different strata, with higher levels in rural
areas. Epilepsy was defined based on self-report, yielding a
prevalence of 0 % to 2 %. This is likely to be an underesti-
mate: qualitative studies conducted in study communities
soon after our survey revealed that epilepsy is a highly
stigmatized disease in both countries (Janet Seeley and
Soori Nnko: personal communications), confirming obser-
vations from others [47, 48]. On the other hand, our find-
ings were in line with those from a study using data from
five demographic surveillance systems from SSA which re-
ported prevalences among adults of 0.5 % to 1.5 % [49].
Lack of awareness was common among people with
hypertension and other CDs, particularly in rural areas.
Frequent lack of awareness and its negative impact on
health outcomes has been documented in other studies
and is a major barrier to control [32, 50]. In patients with
hypertension, the prevalence of awareness was somewhat
higher among ex-smokers, so it is possible that they may
have quit smoking after diagnosis; but it was also higher
among people who were inactive and overweight, suggest-
ing that these groups may have been ill and therefore
sought care, or alternatively that awareness may not ne-
cessarily translate into the adoption of a healthier lifestyle.
Major efforts are needed to educate both the general pub-
lic and individual patients about the threat these NCDs
pose to health, and to promote a healthy lifestyle with
regards to diet, physical activity and appropriate body
weight control [44, 50, 51]. However, this is likely to be a
Table 6 Factors associated with hypertensiona (Continued)
Overweight (25– < 30) 92 / 309 (29.8 %) 2.00 (1.37 -2.92 ) 1.51 (0.94 -2.43 )
Obese (≥30) 52 / 155 (33.5 %) 2.15 (1.34 -3.45 ) 1.57 (0.95 -2.59 )
Waist circumference >94 cm
(M)/>80 cm (F)
P <0.001 P = 0.02
No 235 / 1474 (15.9 %) 1 1
Yes 161 / 531 (30.3 %) 2.47 (1.66 -3.69 ) 1.83 (1.12 - 3.01)
aSystolic BP ≥140 and/or diastolic BP ≥90, in 3rd measurement at a single visit, or currently receiving drugs for high blood pressure; bactual number of
respondents and proportion with hypertension, without sampling weights applied; cstandard errors adjusted for clustering in survey design; dsociodemographic
factors adjusted for age, sex, stratum (a priori) and all independent sociodemographic predictors of hypertension: marital status and education (variables in bold);
ebehavioral factors adjusted for age, sex, stratum, marital status, education and independent behavioral predictors of hypertension: smoking (variables in bold);
fanthropometric factors adjusted for age, sex, stratum, marital status, education and independent behavioral and anthropometric predictors of hypertension:
smoking, BMI category and waist circumference category (variables in bold); gbased on AUDIT screening tool. Non-problem drinking defined as AUDIT score <8;
problem drinking as AUDIT score ≥8. AUDIT, Alcohol Use Disorders Identification Test; BMI, body mass index; CI, confidence interval; USD, US dollars
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Table 7 Factors associated with untreated stage II hypertensiona
Number with stage II hypertension / total
Number (%)b
Age-, sex- and stratum
adjusted OR (95 % CI)c
Adjusted OR
(95 % CI)c,d
Sociodemographic
Age group P <0.001 P <0.001
<35 years 17 / 1163 (1.5 %) 1 1
35–49 years 32 / 448 (7.1 %) 5.54 (3.18 -9.64 ) 4.98 (2.90 -8.54 )
≥50 years 81 / 368 (22.0 %) 22.20 (13.01-37.89) 19.10 (11.48-31.79)
Sex P = 0.31 P = 0.41
Male 50 / 870 (5.7 %) 1 1
Female 80 / 1109 (7.2 %) 1.23 (0.82 -1.84 ) 1.18 (0.79 -1.78 )
Marital status P = 0.38 P = 0.50
Married/living as married 70 / 1191 (5.9 %) 1 1
Divorced/separated/widowed 52 / 336 (15.5 %) 1.34 (0.88 -2.02 ) 1.28 (0.85 -1.92 )
Single 8 / 452 (1.8 %) 0.91 (0.43 -1.94 ) 1.05 (0.49 -2.23 )
Education P = 0.06 P = 0.06
Secondary or above 20 / 664 (3.0 %) 1 1
Primary 40 / 644 (6.2 %) 1.96 (1.01 -3.78 ) 1.96 (1.01 -3.78 )
None/incomplete primary 70 / 671 (10.4 %) 1.91 (1.12 -3.29 ) 1.91 (1.12 -3.29 )
Monthly income (USD) P = 0.34 P = 0.44
Top tertile 15 / 294 (5.1 %) 1 1
Middle tertile 20 / 296 (6.8 %) 1.23 (0.55 -2.74 ) 1.14 (0.50 -2.59 )
Lower tertile 32 / 305 (10.5 %) 1.70 (0.81 -3.58 ) 1.56 (0.74 -3.26 )
Behavioral Adjusted OR (95 % CI)e
Smoking P = 0.20 P = 0.14
Never smoked 107 / 1652 (6.5 %) 1 1
Ex–smoker 10 / 150 (6.7 %) 0.56 (0.27 -1.18 ) 0.53 (0.25 -1.11 )
Current smoker 13 / 176 (7.4 %) 0.61 (0.25 -1.50 ) 0.58 (0.24 -1.41 )
Alcohol consumption P = 0.34 P = 0.38
Never drinks/no drinking in past 12 months 87 / 1499 (5.8 %) 1 1
Non-problem drinkingg 32 / 389 (8.2 %) 1.06 (0.67 -1.69 ) 1.08 (0.67 -1.72 )
Problem drinkingg 10 / 88 (11.4 %) 1.83 (0.81 -4.14 ) 1.80 (0.79 -4.12 )
Eats fruit/veg fewer than five days/week P = 0.57 P = 0.67
No 76 / 1219 (6.2 %) 1 1
Yes 54 / 760 (7.1 %) 1.15 (0.70 -1.89 ) 1.11 (0.68 -1.83 )
Days of vigorous physical activity/week P = 0.31 P = 0.31
None 90 / 1155 (7.8 %) 1.29 (0.76 -2.20 ) 1.33 (0.78 -2.25 )
1–4 6 / 216 (2.8 %) 0.64 (0.26 -1.56 ) 0.66 (0.27 -1.60 )
5+ 34 / 607 (5.6 %) 1 1
Anthropometric Adjusted OR (95 % CI)f
BMI category (kg/m2) P = 0.12 P = 0.85
Underweight (<18.5) 13 / 191 (6.8 %) 0.76 (0.33 – 1.72) 0.84 (0.38 -1.87 )
Normal (18.5– < 25) 65 / 1329 (4.9 %) 1 1
Overweight (25– < 30) 29 / 299 (9.7 %) 1.60 (0.88 – 2.91) 1.01 (0.53 -1.93 )
Obese (≥30) 19 / 144 (13.2 %) 2.11 (1.07 – 4.15) 1.25 (0.61 -2.57 )
Kavishe et al. BMC Medicine  (2015) 13:126 Page 17 of 21
protracted battle in societies that were historically
mainly exposed to acute, infectious health problems,
and among whom malnutrition was common and, con-
sequently, overweight is still regarded as a sign of
health and wealth [52, 53].
A major strength of our research is the relatively large
sample size of our binational study and the carefully-
conducted sampling procedure which ensured popula-
tion representativeness for the areas studied. Another
strength is the use of the STEPS questionnaire as a stan-
dardized interview tool recommended by WHO for
studies on NCDs [15], which allows comparison between
our study and others. Our results are strikingly similar
across the two countries, in particular with respect to
the high prevalence of hypertension and the risk factors
known to be associated with hypertension and diabetes,
thus emphasizing the urgency of our call for effective
public health interventions. The survey is part of a larger
research program in Uganda and Tanzania that focuses
on selected NCDs and HIV infection, based on the ra-
tionale that, from a health services perspective, these
conditions have a number of commonalities [54, 55].
Our study has some weaknesses: There are other im-
portant CDs such as cancers that were not covered by our
survey. CDs were investigated using a variety of diagnostic
procedures. For HIV, hypertension and diabetes, diagnoses
were made using highly sensitive and specific tests. For
obstructive lung disease, chronic heart failure and epi-
lepsy, we were restricted by what was feasible in the field.
The question about physical activities may have been mis-
understood by some survey participants, particularly in
Uganda where the proportion reporting vigorous activity
was much lower than in Tanzania. However, data on lack
of physical activity from Tanzania from our survey (39 %
overall) were comparable to those from the national
STEPS survey (32 %) [43]. The selection of clusters within
5 km of a health facility may have led to overestimation of
the proportion of CD patients diagnosed and treated in
rural areas, implying that the degree of under-treatment
may have been even larger than reported. However, most
rural communities have health facilities, and most people
do not live far away from them.
Our findings have a number of implications for policy
and practice in Tanzania and Uganda and probably else-
where in SSA. The introduction of active case detection
and intensive health education for hypertension and
diabetes in the general population is urgently needed. Ef-
forts are also needed to optimize linkage of NCD pa-
tients to care and ensure their regular follow-up [56].
Health services will need to be generally strengthened to
meet the increasing demand, and we suggest that NCD
services could learn from the successful introduction of
HIV care to peripheral public health services in many
African countries. Such efforts should focus on three
major targets: (1) provision of clinical guidelines, basic
diagnostic equipment, and first- line drug therapy for
NCDs to all health centres and dispensaries; (2) strength-
ening of management systems for NCDs to provide regu-
lar training, supervision, and reporting; and (3) ensuring
sufficient knowledge and experience related to NCDs
among front-line health-care workers [55].
The high prevalence of NCD risk factors and the fact
that the prevalence of diabetes is still comparatively low in
our areas provide a window of opportunity and call for
the urgent introduction of population level and inter-
sectorial interventions to reduce population exposures to
risk factors [57]. Educational mass media campaigns
should be launched to increase awareness about the threat
posed by NCDs and to promote a healthy life style. At
schools, physical activity and traditional diets should be
promoted and actively practiced to the extent possible.
Existing legislation and taxation should be modified
aiming to reduce the consumption of tobacco, alcohol
and unhealthy food and beverages. Such inter-sectorial
preventive measures are reflected in the emerging national
NCD programs in Uganda and Tanzania, and are in line
with recommendations from WHO and the United Na-
tions [58, 59]. The effectiveness of such interventions has
been demonstrated in industrialized countries [60–62].
Conclusions
In this population-based survey of selected CDs from
northwestern Tanzania and southern Uganda, hyperten-
sion prevalence was high and the majority of affected
Table 7 Factors associated with untreated stage II hypertensiona (Continued)
Waist circumference >94 cm (males)/>80 cm (women) P < 0.001 P < 0.001
No 67 / 1468 (4.6 %) 1 1
Yes 62 / 507 (12.2 %) 2.58 (1.49 -4.46 ) 2.72 (1.58 -4.67 )
aSystolic BP ≥160 and/or diastolic BP ≥100 in third measurement at a single visit. Excludes those on treatment for hypertension (9 in Tanzania and 21 in Uganda);
bactual number of respondents and proportion with hypertension, without sampling weights applied; cstandard errors adjusted for clustering in survey design;
dsociodemographic factors adjusted for age, sex, stratum (a priori) and independent sociodemographic predictors of stage II hypertension: education (variables in
bold). ebehavioral factors adjusted for age, sex and stratum (a priori) and education; f anthropometric factors adjusted for age, sex, stratum, education and
independent behavioral and anthropometric predictors of stage II hypertension: waist circumference category; gbased on AUDIT screening tool. Non-problem
drinking defined as AUDIT score <8; problem drinking as AUDIT score ≥8. AUDIT, Alcohol Use Disorders Identification Test; BMI, body mass index; CI, confidence
interval; USD, US dollars
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persons were not aware of their condition, let alone
treated, representing a substantial unmet health need. Risk
factors for hypertension and other NCDs were very com-
mon, suggesting that the burden of other NCDs, such as
diabetes and heart failure, is set to increase. The fact that
their prevalence is still substantially lower in East Africa
than that of hypertension offers a window of opportunity
for prevention efforts at the population level through
educational campaigns and modified legislation and tax-
ation, and at the individual level through risk factor
screening and early disease detection. Such interventions
must be implemented urgently. Health services need to be
strengthened so that they will become able to cope with
the increasing burden of newly-diagnosed NCD patients.
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